Skip to Content
  • MyChart

    Log in to our secure, personalized website to manage your care (formerly myMDAnderson).

  • Request an Appointment

    If you are ready to make an appointment, select a button on the right. If you have questions about UT MD Anderson’s appointment process, our information page may be the best place to start.

    Appointment Information
    New Patients Current Patients Referring Physicians
  • Every Breakthrough
    Begins With You

    Gifts to UT MD Anderson’s historic philanthropic campaign help accelerate discovery, transform lives and bring hope to more patients than ever before.

    Learn more about Only Possible Here
    Donate Today only-possible-here-logo
The University of Texas MD Anderson Cancer Center
  • Clinical Trials
  • Locations
  • Careers
  • Contact Us
  • Our Doctors
    • Español
    • عربى
    • 中文
    • Türkçe
Clear
close
      MyChart
      Donate Today
      • Clinical Trials
      • Locations
      • Careers
      • Contact Us
        • Español
        • عربى
        • 中文
        • Türkçe
      • Request an Appointment
      • New Patients
      • Current Patients
      • Referring Physicians
      • Patients & Family
          • Becoming Our Patient Home
          • Why UT MD Anderson
          • Planning for Care
          • Getting to UT MD Anderson
          • While You're Here
          • International Center
          • Services and Amenities
          • Insurance & Billing
          • Second Opinion Appointments
          • Diagnosis & Treatment Home
          • Cancer Types
          • A New Diagnosis
          • Treatment Options
          • Care Centers & Clinics
          • Emotional & Physical Effects
          • Patient Support
          • Clinical Trials
          • Supporting a Loved One Home
          • Caregiver Roles & Challenges
          • Children and Teens
          • Taking Care of Yourself
          • Helping a UT MD Anderson Patient
          • Dealing with Loss
          • Life After Cancer Home
          • Follow-up Care After Cancer Treatment
          • Long-Term Effects of Cancer
          • Social & Emotional Impacts of Cancer
          • Legal & Financial Impacts of Cancer
          • Survivorship Week
        • Request an Appointment Current Patients

          Find information and resources for current and returning patients.

          Clinical Trials

          Learn about clinical trials at UT MD Anderson and search our database for open studies.

      • Prevention & Screening
          • Manage Your Risk Home
          • Tobacco Control
          • Diet
          • Body Weight
          • Physical Activity
          • Skin Safety
          • HPV
          • Hepatitis
          • Alcohol
          • Family History Home
          • Genetic Testing
          • Hereditary Cancer Syndromes
          • Genetic Counseling and Testing FAQs
          • Cancer Screenings Home
          • Mammograms & Breast Cancer Screening
          • Cervical Cancer Screening
          • Colorectal Cancer Screening
          • Endometrial Cancer Screening
          • Liver Cancer Screening
          • Lung Cancer Screening
          • Mobile Mammography
          • Ovarian Cancer Screening
          • Prostate Cancer Screening
          • Skin Cancer Screening
          • Women's Cancer Screening
          • Men's Cancer Screening
        • Cancer Prevention Center 

          The Lyda Hill Cancer Prevention Center provides cancer risk assessment, screening and diagnostic services.

      • Donors & Volunteers
          • Donate Home
          • Raise Money
          • Honor Loved Ones
          • Create Your Legacy
          • Endowments
          • Caring Fund
          • Matching Gifts
          • Foundation and Corporation Relations
          • Volunteer Home
          • Why Volunteer
          • On-Site Volunteers
          • Volunteer Endowment
          • Patient Experience
          • Teen Volunteer Leadership Program
          • Children's Cancer Hospital Councils
          • Other Ways to Help Home
          • Give Blood
          • Shop UT MD Anderson
          • Children's Art Project
          • Donate Goods or Services
          • Attend Events
          • Cord Blood Bank
          • Corporate Alliances Home
          • Current Alliances
        • Join the Campaign to End Cancer 

          Help us celebrate and fuel the groundbreaking innovations and transformative advancements that define UT MD Anderson.

      • For Physicians
          • Refer a Patient Home
          • Health Care Provider Resource Center
          • Referring Provider Team
          • Insurance Information
          • International Referrals
          • myMDAnderson for Physicians
          • Second Opinion Pathology
          • Clinical Trials Home
          • Clinical Tools & Resources Home
          • Clinical Calculators
          • Clinical Practice Algorithms
        • myMDAnderson for Physicians 

          Our personalized portal helps you refer your patients and communicate with their UT MD Anderson care team.

      • Research
          • Departments, Labs and Institutes Home
          • Departments and Divisions
          • Labs
          • Research Centers and Programs
          • Institutes
          • Specialized Programs of Research Excellence (SPORE) Grants
          • Research Areas Home
          • Basic Science
          • Translational Research
          • Clinical Research
          • Prevention & Personalized Risk Assessment
          • Research Resources Home
          • Excellence in Science
          • Core Facilities and Services
          • Conferences & Seminars
          • Why Research at UT MD Anderson
          • STRIDE
          • NCI-Designated Cancer Center
          • Data Resources
        • Clinical Trials 

          As part of our mission to eliminate cancer, UT MD Anderson researchers conduct hundreds of clinical trials to test new treatments for both common and rare cancers.

      • Education & Training
          • Degree-Granting Schools Home
          • School of Health Professions
          • MD Anderson UTHealth Houston Graduate School
          • Research Training Home
          • Early Career Pathway Programs
          • Predoctoral Training
          • Postdoctoral Training
          • Mentored Faculty Programs
          • Career Development
          • Clinical Training Home
          • Graduate Medical Education
          • Clinical Education for Non-Physicians
          • Nursing Education & Training
          • Continuing Education & Review Courses
          • Simulation Center
          • Continuing Education & Professional Development Home
          • Continuing Professional Education/Conferences
          • Administrative Internships & Fellowships
          • Cancer Survivorship Professional Education
          • Leadership Institute
          • Patient Home Visits
          • Education Resources Home
          • Alumni Relations
          • Education Design Services
          • Awards & Recognitions
          • Academic Mentoring Council
          • Why UT MD Anderson & Houston
          • Outreach Programs Home
          • Project ECHO
          • Observer Programs
          • Comparative Effectiveness Training (CERTaIN)
          • Faculty Speakers Bureau
        • Apply to SHP

          Choose from 12 allied health programs at School of Health Professions.

          Research Trainees

          View open postdoctoral and other research trainee positions.

          GME Fellowships

          Learn about our graduate medical education residency and fellowship opportunities.

      Gregory M. Chronowski Image

      Gregory M. Chronowski, M.D.

      Department of Radiation Oncology, Division of Radiation Oncology

      About Dr. Chronowski

      Dr. Chronowski is a Professor in the Department of Radiation Oncology at MD Anderson Cancer Center and is the Center Medical Director for Radiation Oncology operations in the Houston Area Locations. He completed his pre-medical training at Union College and Columbia University in New York, received his medical degree from Jefferson Medical College in Philadelphia, and completed his Residency in Radiation Oncology at MD Anderson Cancer Center in Houston. Dr. Chronowski joined the faculty of MD Anderson in 2006 and currently practices at the MD Anderson West Houston location, as well as at the Texas Medical Center and Proton Therapy Center locations. Dr. Chronowski currently specializes in the treatment of cancers of the head & neck region, as well as cancers of the prostate.


      Dr. Chronowski has authored and co-authored numerous peer reviewed manuscripts on clinical subjects in Radiation Oncology. He serves in several leadership roles within the MD Anderson Physicians Network working with institutional partners both nationally and internationally.

      Read More

      Meet Gregory Chronowski, M.D.

      Present Title & Affiliation

      Primary Appointment

      Center Medical Director - Radiation Oncology - HAL Operations, Houston Area Locations, The University of Texas MD Anderson Cancer Center, Houston, TX

      Executive Board Member, Cinco Charities, Katy, TX

      Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Dual/Joint/Adjunct Appointment

      Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

      Education & Training

      Degree-Granting Education

      1998Jefferson Medical College, Philadelphia, Pennsylvania, US, MD
      1992Columbia University, New York, New York, US, Medicine, Pre Medical
      1990Union College, Schenectady, New York, US, Biology, BS

      Postgraduate Training

      2025-2025Benign RT Training Course, Radiotherapy Academy for Benign Conditions, RT-ABC;, Chicago, IL
      1999-2003Clinical Residency, University of Texas MD Anderson Cancer Center, Houston, Texas
      1998-1999Clinical Internship, Lankenau Hospital, Wynnewood, Pennsylvania

      Licenses & Certifications

      2020Florida
      2020Mississippi
      2020Arizona
      2020Oklahoma
      2020Georgia
      2020Alabama
      2020Louisiana
      2020Tennessee
      2020Washington
      2018New Mexico Medical Board
      2003American Board of Radiology
      2003Texas Medical Board
      1998National Board of Medical Examiners

      Experience & Service

      Faculty Academic Appointments

      Associate Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2006 - 2011

      Assistant Professor, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2001 - 2006

      Administrative Appointments/Responsibilities

      Clinical Site Director, Radiation Oncology, The University of Texas MD Anderson Cancer Center @ Scripps, San Diego, CA, 2022 - Present

      Center Medical Director - Radiation Oncology - HAL Operations, Houston Area Locations, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

      Clinical Site Director, Radiation Oncology, The University of Texas MD Anderson Cancer Center @ UTHSA, San Antonio, TX, 2020 - 2021

      Clinical Site Director, Radiation Oncology, The University of Texas MD Anderson Cancer Center at Cooper, Camden, NJ, 2019 - Present

      Section Chief, Radiation Oncology, Presbyterian MD Anderson Radiation Treatment Center, Albuquerque, NM, 2016 - 2021

      Assistant Section Chief, Radiation Oncology, The University of Texas MD Anderson Cancer Center - HALs, Houston, TX, 2016 - 2018

      Department Chair ad interim, Radiation Oncology, The University of Texas MD Anderson Cancer Center at Cooper, Camden, NJ, 2015 - 2017

      Other Professional Positions

      Chair of Cooper Search Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2017

      Executive Board Member, Cinco Charities, Katy, TX, 2014 - Present

      Member of Medical Executive Committee, Christus St. Catherine's Hospital, Katy, TX, 2009 - 2014

      Member of Ethics Committee, Christus St. Catherine's Hospital, Katy, TX, 2009 - 2014

      Chair Cancer Committee, Christus St. Catherine's Hospital, Katy, TX, 2007 - 2014

      Physician Liaison to the American Cancer Society, Edward Hospital, Naperville, IL, 2004 - 2006

      Medical Staff, Edward Hospital, Naperville, IL, 2003 - 2006

      Associate, Midwest Radiation Oncology Consultants, Elgin, IL, 2003 - 2006

      Member, Edward Hospital Cancer Committee, Naperville, IL, 2003 - 2006

      Extramural Institutional Committee Activities

      Member, BMT Steering Committee - Cooper, The University of Texas MD Anderson Cancer Center, 2022 - Present

      Member, Admissions Committee for Radiation Oncology, The University of Texas MD Anderson Cancer Center, 2015 - Present

      Head, Regional Care Center Working Group, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Reviewer of Radiation Oncology Practice, MD Anderson Physician's Network Host Affiliate Program, The University of Texas MD Anderson Cancer Center, 2010 - Present

      Member, Clinical Head and Neck Team Recruited to Evaluate and Treat a Head-of-State in Lausanne, Switzerland, The University of Texas MD Anderson Cancer Center, 2010 - 2012

      Honors & Awards

      2023 - 2024PRS & Patient Experience Top 1% Provider, Press Ganey - Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CGCAHPS)
      2022 - 2024Top Doctor of Texas 2022, Castle Connolly
      2022 - 2024Top Radiation Oncologist, America's Best Doctors
      2022 - 2024Top Radiologist 2022, Magazine Top Doctors
      2020 - 2021Top Doctor 2020, TX Top Docs
      20182018 Top Performers, Clinician and Group Consumer Assessment of Healthcare Providers and Systems
      2001Travel Award for Clinical Epidemiological Symposium, Berlex Oncology Foundation
      1998Hobart Armory Hare Honor Society, Sidney Kimmel Medical College

      Professional Memberships

      American Society for Therapeutic Radiology and Oncology

      2004 - Present

      American Society for Therapeutic Radiology and Oncology

      2004 - Present

      Association of Residents in Radiation Oncology

      2004

      American Board of Radiology

      2003 - Present

      American Medical Association

      2003

      Accreditation Council for Graduate Medical Education (ACGME)

      2001 - 2003

      Association of Residents in Radiation Oncology (ARRO)

      2001 - 2003

      Association of Residents in Radiation Oncology

      2001 - 2003

      American Society for Therapeutic Radiology and Oncology

      1998 - Present

      Gilbert H. Fletcher Society

      1998

      Selected Presentations & Talks

      Local Presentations

      1. 2025. Oral Cavity: complex anatomy, case variations, contouring plan review & image guidance. Invited. NERO Conference 2025 (Thoracic). Houston, Texas, US.
      2. 2022. Medical Minute. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      3. 2019. Oropharyngeal & Unknown Primary Carcinoma: Contouring & Treatment Issues. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      4. 2019. Panel Discussion and Q&A. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
      5. 2019. Introduction/Overview. Conference. M D Anderson Cancer Center. Houston, TX, US.
      6. 2008. Institutional Grand Rounds: "Swing of the Pendulum: Evolution of Function-sparing Treatment for Head and Neck Cancer. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.

      Regional Presentations

      1. 2017. Radiation treatment for lung cancer. Conference. Cooper Health University. Camden, NJ, US.
      2. 2012. HPV infection and the Development of Oropharyngeal Cancer. Conference. The University of Texas MD Anderson Cancer Center - Sugarland Houston Area Location. Sugarland, TX, US.

      National Presentations

      1. 2017. Poster Presentation: HPV-Related Oropharyngeal Cancers: An evidence-based overview for ambulatory care nurses. Conference. 2017 Oncology Nursing Society Annual Congress. Denver, CO, US.
      2. 2017. Radiation treatment for lung cancer - Lung Symposium. Conference. Cooper Health University. Camden, NJ, US.
      3. 2010. Plenary Session Unilateral Radiotherapy for Carcinoma of the Tonsil. Invited. Multidisciplinary Head and Neck Symposium. Chandler, AZ, US.
      4. 2006. American Society for Therapeutic Radiology and Oncology Annual Meeting Practice Entry Seminar - ARRO. Invited. American Society for Therapeutic Radiology and Oncology. Philadelphia, PA, US.
      5. 2005. Practice Entry Seminar, The ABR written and oral board exam. Invited. Association of Residents in Radiation Oncology. Denver, CO, US.
      Read More
      Less

      Selected Publications

      Peer-Reviewed Articles

      1. Frank, SJ, Busse, PM, Lee, JJ, Rosenthal, D, Hernandez, M, Swanson, DM, Garden, AS, Gunn, GB, Patel, SH, Snider, JW, Ma, DJ, Molitoris, JK, Lee, N, Parvathaneni, U, McDonald, MW, Kalman, NS, Lin, A, Mohammed, N, Henson, CE, Hyde, C, Bajaj, GK, Katz, SR, Dagan, R, Morrison, WH, Reddy, JP, Fuller, C, Shah, SJ, Phan, J, Chronowski, G, Mayo, LL, Sturgis, EM, Ferrarotto, R, Zhu, XR, Zhang, X, Wang, L, Hutcheson, KA, El-Naggar, AK, Moreno, AC, Lee, A, Spiotto, MT, Gross, N, Lai, SY, Liao, JJ, Paly, JJ, Liao, Z, Foote, RL, Bates, JE, Chambers, MS, Chun, SG, Kaiser, A, Lester, SC, Lukens, JN, McGee, LA, Neben-Wittich, MA, Nguyen, Q, Routman, DM, Schlembach, PJ, Skinner, H, Soike, MH, Rwigema, JM, Wiederhold, LR, Blanchard, P, Choi, I, Koong, A, Langendijk, H, Mohan, R, Carlson, BJ, Mapps, A, Sarmiento, JG, Teferra, MY, Bosch, WR, Followill, DS, Taylor, PA, Fuentes, SY, Ning, M, Toumazis, I, Wogan, CF, De Gracia, B, Fink, K, Grippin, A, Ma, J, Pettersen, EA, Sareyeldin, RM, Cronin, C, Muise, S, Johnson, M, Pyfferoen, K, Tranby, BN, Leonard, J, Watkin, S, Eggleston, C, Barrow, B, Wolcott, J, Antonio, J, Brand, J, Cleverdon, A, Drake, M, Peters, E, Small, C, Clark, K, Holder, R. Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA. The Lancet 407(10524):174-184, 2026. e-Pub 2026. PMID: 41391462.
      2. Abana, CO, Garden, AS, Gunn, GB, Chronowski, G, Mohamed, AS, Frankart, AJ, Geier, N, Bahig, H, Barbon, CE, Hutcheson, KA, Takiar, V, Fuller, C, Frank, SJ, Rosenthal, D, Phan, J. Patient-reported outcomes after ipsilateral radiation therapy for N2b tonsillar squamous cell carcinoma. Discover Oncology 16(1), 2025. e-Pub 2025. PMID: 41288848.
      3. Sahin, O, Kamel, S, Wahid, K, Dede, C, Taku, N, He, R, Naser, M, Sharafi, CS, Mäkitie, AA, Kann, BH, Kaski, K, Sahlsten, J, Jaskari, J, Amit, M, Chronowski, G, Diaz Jr, EM, Garden, AS, Goepfert, RP, Guenette, JP, Gunn, GB, Hirvonen, J, Hoebers, F, Hutcheson, KA, Guha-Thakurta, N, Johnson, JM, Kaya, D, Khanpara, SD, Nyman, K, Lai, SY, Lango, MN, Learned, KO, Lee, A, Lewis, CM, Maniakas, A, Moreno, AC, Myers, JN, Phan, J, Pytynia, KB, Rosenthal, D, Sandulache, VC, Schellingerhout, D, Shah, SJ, Sikora, AG, Mohamed, AS, Chen, MM, Fuller, C. International multispecialty expert physician preoperative identification of extranodal extension in patients with oropharyngeal cancer using computed tomography. Cancer 131(7), 2025. e-Pub 2025. PMID: 40159431.
      4. Tino R, Roach MA, Fuentes GD, Agrawal A, Zaid M, Cooper DJ, Bajaj N, Lin R, Xiao L, Mayo LL, Wiederhold LR, Shah SJ, Tate MK, Chronowski GM, Reddy JP, Mezera M, Mann JM, Augspurger M, Otun AO, Chambers MS, Koay EJ. Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy. Oral Oncol 157:106944, 2024. e-Pub 2024. PMID: 39024700.
      5. Working Group MOCEEA, Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi S, Mäkitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. International Multi-Specialty Expert Physician Preoperative Identification of Extranodal Extension n Oropharyngeal Cancer Patients using Computed Tomography: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2024. e-Pub 2024. PMID: 36865096.
      6. Weng J, Mesko S, Chronowski G, Lee P, Choi S, Das P, Koong AC, French K, Aloia T, Ehlers R, Elrod-Joplin D, Kerr A, Smith R, Martinez W, Bloom E, Shah SJ, Ning MS, Liao Z, Herman J, Moningi S, Moreno AC, Nguyen QN. Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing: Efficiency and Financial Impacts. JCO Oncol Pract 20(5):OP2300037, 2024. e-Pub 2024. PMID: 38330252.
      7. Ludmir EB, Hoffman KE, Jhingran A, Kouzy R, Ip MP, Sturdevant L, Ning MS, Minsky BD, McAleer MF, Chronowski GM, Arzu IY, Reed VK, Garg AK, Roberts T, Eastwick GA, Olson MR, Selek U, Gabel M, Koong AC, Kupferman ME, Kuban DA. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network. Pract Radiat Oncol 14(3):e173-e179, 2024. e-Pub 2024. PMID: 38176466.
      8. Contrera, KJ, Tam, S, Pytynia, KB, Diaz Jr, EM, Hessel, AC, Goepfert, RP, Lango, MN, Su, SY, Myers, JN, Weber, RS, Eguia, A, Pisters, PW, Adair, DK, Nair, AS, Rosenthal, D, Mayo, LL, Chronowski, G, Zafereo, M, Shah, SJ. ASO Visual Abstract. Annals of surgical oncology 30(4):2341-2342, 2023. e-Pub 2023. PMID: 36720835.
      9. Contrera KJ, Tam S, Pytynia K, Diaz EM, Hessel AC, Goepfert RP, Lango M, Su SY, Myers JN, Weber RS, Eguia A, Pisters PWT, Adair DK, Nair AS, Rosenthal DI, Mayo L, Chronowski GM, Zafereo ME, Shah SJ. Impact of Cancer Care Regionalization on Patient Volume. Ann Surg Oncol 30(4):2331-2338, 2023. e-Pub 2023. PMID: 36581726.
      10. Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, Chronowski GM, Fuller CD, Gross ND, Hutcheson KA. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg 167(3):1945998211059967, 2022. e-Pub 2022. PMID: 34784256.
      11. Taku N, Chronowski G, Brandon Gunn G, Morrison WH, Gross ND, Moreno AC, Ferrarotto R, Frank SJ, Fuller CD, Goepfert RP, Phan J, Lai SY, Reddy JP, Rosenthal DI, Garden AS. Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 113(5):1054-1062, 2022. e-Pub 2022. PMID: 35504500.
      12. Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys 111(2):360-370, 2021. e-Pub 2021. PMID: 33992718.
      13. Gunn, GB, Garden, AS, Ye, R, Ausat, N, Dahlstrom, KR, Morrison, WH, Fuller, C, Phan, J, Reddy, JP, Shah, SJ, Mayo, LL, Chun, SG, Chronowski, G, Moreno, AC, Myers, JN, Hanna, EY, Esmaeli, B, Gillison, M, Ferrarotto, R, Hutcheson, KA, Chambers, MS, Ginsberg, LE, El-Naggar, AK, Rosenthal, D, Zhu, XR, Frank, SJ. Proton therapy for head and neck cancer. International Journal of Particle Therapy 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
      14. Hanania, A, Zhang, X, Gunn, GB, Rosenthal, D, Garden, AS, Fuller, C, Phan, J, Reddy, JP, Moreno, AC, Chronowski, G, Shah, SJ, Ausat, N, Hanna, EY, Ferrarotto, R, Frank, SJ. Proton therapy for major salivary gland cancer. International Journal of Particle Therapy 8(1):261-272, 2021. e-Pub 2021. PMID: 34285952.
      15. Smith, GL, Fu, S, Ning, M, Nguyen, DK, Busse, PM, Foote, RL, Garden, AS, Gunn, GB, Fuller, C, Morrison, WH, Chronowski, G, Shah, SJ, Mayo, LL, Phan, J, Reddy, JP, Snider, JW, Patel, SH, Katz, SR, Lin, A, Mohammed, N, Dagan, R, Lee, N, Rosenthal, D, Frank, SJ. Work outcomes after intensity- modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for oropharyngeal cancer. International Journal of Particle Therapy 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
      16. Augustyn A, Reed VI, Ahmad N, Bhutani MS, Bloom ES, Bowers JR, Chronowski GM, Das P, Holliday EB, Delclos ME, Huey RW, Koay EJ, Lee SS, Nelson CL, Taniguchi CM, Koong AC, Chun SG. Implementation of a stereotactic body radiotherapy program for unresectable pancreatic cancer in an integrated community academic radiation oncology satellite network. Clin Transl Radiat Oncol 27:147-151, 2021. e-Pub 2021. PMID: 33665384.
      17. Ning MS, McAleer MF, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Gunn GB, Klopp AH, Dabaja BS, Nguyen QN, Chronowski GM, Bloom ES, Koong AC, Das P. Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol 148:252-257, 2020. e-Pub 2020. PMID: 32474129.
      18. Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
      19. Ludmir EB, Adlakha EK, Chun SG, Reed VK, Arzu IY, Ahmad N, Bloom E, Chronowski GM, Delclos ME, Mayo LL, Schlembach PJ, Liao Z, Koong AC, Herman JM, Shah SJ. Enhancing clinical trial enrollment at MD Anderson Cancer Center satellite community campuses. Acta Oncol 58(8):1-3, 2019. e-Pub 2019. PMID: 30958082.
      20. Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BD. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol:JCO1800317. e-Pub 2018. PMID: 30379626.
      21. Lewis CM, Chronowski GM, Dong W, Gunn GB, Rosenthal DI, Weber RS. Analysis of Charges Associated with Definitive Nonsurgical Therapy for Early-Stage Lateralized Tonsil Cancer. Ann Surg Oncol 22(8):2755-60, 2015. e-Pub 2015. PMID: 25519929.
      22. Schwartz DL, Garden AS, Shah SJ, Chronowski GM, Sejpal S, Rosenthal DI, Chen Y, Zhang Y, Zhang L, Wong PF, Garcia JA, Kian Ang K, Dong L. Adaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trial. Radio Oncol 106(1):80-4, 2013. e-Pub 2013. PMID: 23369744.
      23. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Gunn GB, Kupferman ME, Ang KK, Rosenthal DI. Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 83(1):204-9, 2012. e-Pub 2012. PMID: 22019242.
      24. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective imaging assessment of mortality risk after head-and-neck radiotherapy. Int J Radiat Oncol Biol Phys 78(3):667-74, 2010. e-Pub 2010. PMID: 20171802.
      25. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure. Int J Radiat Oncol Biol Phys 78(4):1005-10, 2010. e-Pub 2010. PMID: 20207504.
      26. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27(15):2509-15, 2009. e-Pub 2009. PMID: 19332725.
      27. Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, Kavadi V, Liengswangwong V, Goardon W, Raben A, Strasser J, Koprowski C, Frank S, Chronowski GM, Ahamad A, Malyapa R, Zhang L, Dong L. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 68(5):1512-21, 2007. e-Pub 2007. PMID: 17674982.
      28. Pelloski CE, Palmer M, Chronowski GM, Jhingran A, Horton J, Eifel PJ. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62(1):131-7, 2005. e-Pub 2005. PMID: 15850913.
      29. Jagsi R, Chronowski GM, Buck DA, Kang S, Palermo J. Association of Residents in Radiation Oncology Executive Committee. Special report: results of the 2000-2002 Association of Residents in Radiation Oncology (ARRO) surveys. Int J Radiat Oncol Biol Phys 59(1):313-8, 2004. e-Pub 2004. PMID: 15093928.
      30. Chronowski GM, Wilder RB, Levy LB, Atkinson EN, Ha CS, Hagemeister FB, Barista I, Rodriguez MA, Sarris AH, Hess MA, Cabanillas F, Cox JD. Second malignancies after chemotherapy and radiotherapy for Hodgkin disease. Am J Clin Oncol 27(1):73-80, 2004. e-Pub 2004. PMID: 14758137.
      31. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy. Int J Radiat Oncol Biol Phys 55(1):36-43, 2003. e-Pub 2003. PMID: 12504034.
      32. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Cancer 95(12):2534-8, 2002. e-Pub 2002. PMID: 12467067.
      33. Wilder RB, Schlembach PJ, Jones D, Chronowski GM, Ha CS, Younes A, Hagemeister FB, Barista I, Cabanillas F, Cox JD. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease. Cancer 94(6):1731-8, 2002. e-Pub 2002. PMID: 11920535.
      34. Chronowski GM, Ha CS, Wilder RB, Cabanillas F, Manning J, Cox JD. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92(3):670-6, 2001. e-Pub 2001. PMID: 11505414.
      35. Laurie SA, Pfister DG, Kris MG, Tong WP, Chronowski GM, Pisters KM, Heelan RT, Sirotnak FM. Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin. Clin Cancer Res 7(3):501-9, 2001. e-Pub 2001. PMID: 11297240.

      Review Articles

      1. Taku N, Wang L, Garden AS, Rosenthal DI, Gunn GB, Morrison WH, Fuller CD, Phan J, Reddy JP, Moreno AC, Spiotto MT, Chronowski G, Shah SJ, Mayo LL, Gross ND, Ferrarotto R, Zhu XR, Zhang X, Frank SJ. Proton Therapy for HPV-Associated Oropharyngeal Cancers of the Head and Neck: a De-Intensification Strategy. Curr Treat Options Oncol 22(6):54, 2021. e-Pub 2021. PMID: 34086150.
      2. Ballo MT, Chronowski GM, Schlembach PJ, Bloom ES, Arzu IY, Kuban DA. Prospective peer review quality assurance for outpatient radiation therapy. Pract Radiat Oncol 4(5):279-284, 2014. e-Pub 2014. PMID: 25194094.
      3. Chronowski GM, Buchholz TA. Accelerated partial breast irradiation. Curr Probl Cancer 31(1):7-25, 2007. e-Pub 2007. PMID: 17254900.

      Editorials

      1. Chronowski GM, Bloom ES. Commentary, Prone Accelerated Partial Breast Irradiation After Breast Conserving Surgery: Five-Year Results of 100 Patients. Breast Diseases: A Year Book Quarterly 24(2), 2013.
      2. Bloom ES, Chronowski GM. Commentary, External Beam Accelerated Partial Breast Irradiation Using 32Gy in 8 Twice-Daily Fractions: 5-Year Results of a Prospective Study. Breast Diseases: A Year Book Quarterly 24(2), 2013.

      Abstracts

      1. Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BD. Acute and Short-Term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol 1(7):931-41, 2015. e-Pub 2015.
      2. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-8, 2015. e-Pub 2015.

      Book Chapters

      1. Chronowski GM, Buchholz TA. Radiation therapy in breast conserving therapy for invasive breast cancer-commentary. In: Principles and practice of surgical oncology. 1st. Lippincott Williams & Wilkins, 393-96, 2010.
      2. Chao C, Mohan R, Lee N, Chronowski G, Low D, Wu G, Dong L. Intensity modulated radiation treatment planning, quality assurance, delivery and clinical application. In: Principles and practices of radiation oncology. 5th. Lippincott Williams & Wilkins, 239-62, 2008.
      3. Chronowski GM, Rosenthal DI. Chemoradiation for head and neck cancer. In: Options in the treatment of head and neck cancer. 1st. CMP medica, 2006.
      4. Chronowski GM. Advice for the unsuccessful applicant. 8th. Ed(s). In: Getting into medical school. 8th, 266-74, 1997.

      Letters to the Editor

      1. Tino, R, Roach, MA, Fuentes, GD, Agrawal, A, Zaid, M, Cooper, DJ, Bajaj, N, Lin, R, Xiao, L, Mayo, LL, Wiederhold, LR, Shah, SJ, Tate, MK, Chronowski, G, Reddy, JP, Mezera, M, Mann, JM, Augspurger, ME, Otun, AO, Chambers, MS, Lee, A, Koay, EJ. Response to recent comments on “Development and clinical implementation of a digital workflow utilizing 3D-printed oral stents for patients with head and neck cancer receiving radiotherapy”. Oral Oncology 162, 2025.
      2. Chronowski GM, Rosenthal DI. In Reply to Geropantas et al. Re: Unilateral radiotherapy for the treatment of tonsil cancer. Int J Radiat Oncol Biol Phys 85: 8, 2013.
      Read More
      Less

      Patient Reviews


      CV information above last modified July 28, 2026

      Request an Appointment

      Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.
      Learn more

      Related Links

      • Radiation Treatment Center

      • Radiation Oncology Department

      • Radiation Oncology Division

      Clinical Trials

      Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.
      Learn more

      Help #EndCancer

      Give Now

      Your gift will help make a tremendous difference.
      Donate

      Donate Blood

      Our patients depend on blood and platelet donations.

      Make an appointment

      Shop UT MD Anderson

      Show your support for our mission through branded merchandise.

      View products
      Subscribe to our Cancerwise newsletter
      UT MD Anderson logoUT MD Anderson logo
      • Explore
      • Patients & Family
      • Prevention & Screening
      • Donors & Volunteers
      • For Physicians
      • Research
      • Education & Training
      • Clinical Trials
      • Languages
      • About
      • About UT MD Anderson
      • Careers
      • Blog
      • Newsroom
      • Editorial Standards
      • For Employees
      • Merchandise
      • Title IX Reporting (Sexual Misconduct)
      • Price Transparency
      • Finding Your Way
      • Our Doctors
      • Locations
      • Directions
      • Sitemap
      • DIGITAL ACCESSIBILITY
      • Accessibility Policy MD Anderson works with Level Access to ensure our website is accessible and functional for all users. Free assistive technology is provided for people with physical disabilities. To learn more or to download the assistive technology tool, visit https://www.levelaccess.com/MDAnderson
      • GET IN TOUCH
      • Call
        1-877-632-6789
      • Ask a question
      • Stay Connected
      • Cancerwise Podcast
      • More
      • Website Privacy Policy
      • Legal Statement & Policies
      • Reports to the State
      • Emergency Alert Information
      • State of Texas Links
      • Our Cancer Network
      • Vendors & Suppliers
      UT MD Anderson logo
      The mission of The University of Texas MD Anderson Cancer Center is to eliminate cancer in Texas, the nation, and the world through outstanding programs that integrate patient care, research and prevention, and through education for undergraduate and graduate students, trainees, professionals, employees and the public.

      © 2026 The University of Texas MD Anderson Cancer Center. All rights reserved.

      Top